BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 107 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,530 | -62.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $6,660 | -64.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $18,660 | -13.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $21,480 | +53.4% | 1,000 | -18.4% | 0.00% | – |
| Q3 2022 | $14,000 | +7.7% | 1,226 | +22.6% | 0.00% | – |
| Q2 2022 | $13,000 | -43.5% | 1,000 | -10.5% | 0.00% | – |
| Q1 2022 | $23,000 | 0.0% | 1,117 | 0.0% | 0.00% | – |
| Q4 2021 | $23,000 | -32.4% | 1,117 | 0.0% | 0.00% | – |
| Q3 2021 | $34,000 | +6.2% | 1,117 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | -33.3% | 1,117 | 0.0% | 0.00% | – |
| Q1 2021 | $48,000 | -7.7% | 1,117 | 0.0% | 0.00% | – |
| Q4 2020 | $52,000 | +8.3% | 1,117 | 0.0% | 0.00% | – |
| Q3 2020 | $48,000 | -9.4% | 1,117 | +11.7% | 0.00% | – |
| Q2 2020 | $53,000 | +140.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $22,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |